- €2.04bn
- €2.98bn
- €1.51bn
- 34
- 45
- 73
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,270 | 1,207 | 1,405 | 1,805 | 1,514 |
Cost of Revenue | |||||
Gross Profit | 458 | 340 | 441 | 615 | 372 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 972 | 1,015 | 1,089 | 1,310 | 1,283 |
Operating Profit | 298 | 192 | 317 | 496 | 231 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 303 | 189 | 318 | 487 | 231 |
Provision for Income Taxes | |||||
Net Income After Taxes | 261 | 187 | 290 | 434 | 201 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 226 | 161 | 253 | 391 | 184 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 226 | 161 | 253 | 391 | 184 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.69 | 5.48 | 8.53 | 12.9 | 6.27 |
Dividends per Share |